Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women, aged 18-85 with who have previously had the InterStim device implanted and have experienced good control of their symptoms for at least one year.~Exclusion Criteria:~* Patients with less than 6 months of expected battery life on their device established at office testing.~* Patients with poor control of their symptoms within the last one year.~* Patients with degenerative neurological disorders or spinal cord injuries.~* Patients with cognitive disabilities or those lacking the mental capacity to understand and answer questionnaires.~* Patients who are pregnant or may become pregnant.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Sacral neuromodulation device turned off (Type: OTHER): Patients who are currently being successfully treated with sacral neuromodulation for the primary diagnosis of urinary urge incontinence or urgency and frequency (implantation for minimum 12 months) will be to have the sacral neuromodulation device turned off for four consecutive weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).